Literature DB >> 1870095

Autosomal dominant inheritance of abnormalities of the hands and feet with short palpebral fissures, variable microcephaly with learning disability, and oesophageal/duodenal atresia.

H G Brunner1, R M Winter.   

Abstract

We report two families with an autosomal dominant syndrome of abnormalities of the hands and feet, short palpebral fissures, and variable microcephaly with learning disability. Between a third and a quarter of cases are born with oesophageal atresia, duodenal atresia, or both. Individual patients have hypoplastic thumbs or congenital heart disease. The phenotype of the syndrome reported here is similar to that observed in 13q22-qter deletion patients. However, chromosome analysis has not detected any structural abnormality in our patients.

Entities:  

Mesh:

Year:  1991        PMID: 1870095      PMCID: PMC1016903          DOI: 10.1136/jmg.28.6.389

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

Review 1.  Familial duodenal atresia: a report of two families and review.

Authors:  L G Best; N E Wiseman; A E Chudley
Journal:  Am J Med Genet       Date:  1989-11

Review 2.  Family studies on congenital esophageal atresia with or without tracheoesophageal fistula.

Authors:  H Chen; G S Goei; J H Hertzler
Journal:  Birth Defects Orig Artic Ser       Date:  1979

3.  Offspring of patients with tracheo-oesophageal fistula.

Authors:  J Warren; K Evans; C O Carter
Journal:  J Med Genet       Date:  1979-10       Impact factor: 6.318

4.  Etiological study on isolated esophageal atresia.

Authors:  T Szendrey; G Danyi; A Czeizel
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  An unusual microcephaly.

Authors:  M Feingold
Journal:  Hosp Pract       Date:  1978-02

Review 6.  Microcephaly: general considerations and aids to nosology.

Authors:  J M Opitz; M C Holt
Journal:  J Craniofac Genet Dev Biol       Date:  1990

7.  Auralcephalosyndactyly: a new hereditary craniosynostosis syndrome.

Authors:  T W Kurczynski; S M Casperson
Journal:  J Med Genet       Date:  1988-07       Impact factor: 6.318

8.  Oesophageal atresia in the South West of England.

Authors:  T J David; S E O'Callaghan
Journal:  J Med Genet       Date:  1975-03       Impact factor: 6.318

9.  Familial congenital esophageal atresia. Personal case report and review of the literature.

Authors:  M Van Staey; S De Bie; M T Matton; J De Roose
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Clinical/epidemiological analysis of malformations.

Authors:  M L Martinez-Frías; J L Frías; J Salvador
Journal:  Am J Med Genet       Date:  1990-01
  10 in total
  5 in total

1.  Familial syndromic esophageal atresia maps to 2p23-p24.

Authors:  J Celli; E van Beusekom; R C Hennekam; M E Gallardo; D F Smeets; S R de Córdoba; J W Innis; M Frydman; R König; H Kingston; J Tolmie; L C Govaerts; H van Bokhoven; H G Brunner
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Myocardial Mycn is essential for mouse ventricular wall morphogenesis.

Authors:  Cristina Harmelink; Yin Peng; Paige DeBenedittis; Hanying Chen; Weinian Shou; Kai Jiao
Journal:  Dev Biol       Date:  2012-10-12       Impact factor: 3.582

Review 3.  Oesophageal atresia.

Authors:  Lewis Spitz
Journal:  Orphanet J Rare Dis       Date:  2007-05-11       Impact factor: 4.123

Review 4.  The multifactorial origin of respiratory morbidity in patients surviving neonatal repair of esophageal atresia.

Authors:  Ana Catarina Fragoso; Juan A Tovar
Journal:  Front Pediatr       Date:  2014-05-05       Impact factor: 3.418

5.  Histological, immunohistochemical and transcriptomic characterization of human tracheoesophageal fistulas.

Authors:  Erwin Brosens; Janine F Felix; Anne Boerema-de Munck; Elisabeth M de Jong; Elisabeth M Lodder; Sigrid Swagemakers; Marjon Buscop-van Kempen; Ronald R de Krijger; Rene M H Wijnen; Wilfred F J van IJcken; Peter van der Spek; Annelies de Klein; Dick Tibboel; Robbert J Rottier
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.